Exploring the therapeutic potential of Xiangsha Liujunzi Wan in Crohn's disease
From network pharmacology approach to experimental validation
Bibliographic Data
| ID | 14743153 |
|---|---|
| Authors | Linlin Zheng (0000-0002-8902-1056, China Medical University), Ziyun Wei (0000-0001-8913-1389, China Medical University), Xiao Ni (0000-0002-8159-9275, China Medical University), Jianing Shang (China Medical University), Fu Liu (0000-0003-1461-9608, China Medical University), Yuxuan Peng (0000-0001-7874-1368, China Medical University), Jieyu Liu (0000-0001-8330-5376, China Medical University, corresponding author), Yunwei Li (0000-0002-5410-4505, First Hospital of China Medical University, corresponding author) |
| Year | 2025 |
| Volume | 337 |
| Issue | Pt 2 |
| Pages | 118863 |
| Publication date | 2025-01-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2024.118863 |
| PMID | 39343107 |
| OpenAlex | W4402913712 |
| Language | EN |
| Citations received | 1 |
| References cited | 61 |
LJZW has the characteristics of multi-component, multi-target, and multi-pathway treatment, which helps to improve the treatment of CD, protect the intestinal barrier, and exert the effect of anti-inflammatory therapy by inhibiting PI3K-AKT and MAPK signaling pathways
Crohn's disease · Disease · Traditional medicine · Medicine · Natural product bioactivities and synthesis · Pharmacological Effects of Natural Compounds · Phytochemistry and Bioactive Compounds · Internal Medicine · Pharmacology
| Citations per year | 1 |
|---|---|
| Citation span | 2025 - 2025 (1) |
| Highly cited | No |